These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 7871155)

  • 21. [Neutron capture therapy for cancer].
    Fukuda H; Ichihashi M; Mishima Y
    Gan To Kagaku Ryoho; 1994 Feb; 21(3):374-8. PubMed ID: 8109994
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A bystander effect observed in boron neutron capture therapy: a study of the induction of mutations in the HPRT locus.
    Kinashi Y; Masunaga S; Nagata K; Suzuki M; Takahashi S; Ono K
    Int J Radiat Oncol Biol Phys; 2007 Jun; 68(2):508-14. PubMed ID: 17418970
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Improvement of the tumor-suppressive effect of boron neutron capture therapy for amelanotic melanoma by intratumoral injection of the tyrosinase gene.
    Morita N; Hiratsuka J; Kondoh H; Uno M; Asano T; Niki Y; Sakurai Y; Ono K; Harada T; Imajo Y
    Cancer Res; 2006 Apr; 66(7):3747-53. PubMed ID: 16585201
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Analysis of 10B antitumoral compounds by means of flow-injection into ESI-MS/MS.
    Basilico F; Sauerwein W; Pozzi F; Wittig A; Moss R; Mauri PL
    J Mass Spectrom; 2005 Dec; 40(12):1546-9. PubMed ID: 16320299
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synthesis and evaluation of a boronated nitroimidazole for boron neutron capture therapy.
    Swenson DH; Laster BH; Metzger RL
    J Med Chem; 1996 Mar; 39(7):1540-4. PubMed ID: 8691485
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Boron neutron capture therapy of malignant melanoma using 10B-paraboronophenylalanine with special reference to evaluation of radiation dose and damage to the normal skin.
    Fukuda H; Hiratsuka J; Honda C; Kobayashi T; Yoshino K; Karashima H; Takahashi J; Abe Y; Kanda K; Ichihashi M
    Radiat Res; 1994 Jun; 138(3):435-42. PubMed ID: 8184019
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hyaluronan as carrier of carboranes for tumor targeting in boron neutron capture therapy.
    Meo CD; Panza L; Capitani D; Mannina L; Banzato A; Rondina M; Renier D; Rosato A; Crescenzi V
    Biomacromolecules; 2007 Feb; 8(2):552-9. PubMed ID: 17291079
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Critical evaluation of bispecific antibodies as targeting agents for boron neutron capture therapy of brain tumors.
    Liu L; Barth RF; Adams DM; Soloway AH; Reisfeld RA
    Anticancer Res; 1996; 16(5A):2581-7. PubMed ID: 8917355
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Insight into the mechanisms underlying tumor response to boron neutron capture therapy in the hamster cheek pouch oral cancer model.
    Aromando RF; Heber EM; Trivillin VA; Nigg DW; Schwint AE; Itoiz ME
    J Oral Pathol Med; 2009 May; 38(5):448-54. PubMed ID: 19141057
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Biodistribution of GB-10 (Na(2)(10)B10H10 compound for boron neutron capture therapy (BNCT) in an experimental model of oral cancer in the hamster cheek pouch.
    Heber E; Trivillin VA; Nigg D; Kreimann EL; Itoiz ME; Rebagliati RJ; Batistoni D; Schwint AE
    Arch Oral Biol; 2004 Apr; 49(4):313-24. PubMed ID: 15003550
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vitro neutron irradiation of glioma and endothelial cultured cells.
    Menichetti L; Gaetano L; Zampolli A; Del Turco S; Ferrari C; Bortolussi S; Stella S; Altieri S; Salvadori PA; Cionini L
    Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S336-40. PubMed ID: 19410472
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neutron capture therapy of a rat glioma using boronophenylalanine as a capture agent.
    Matalka KZ; Barth RF; Staubus AE; Moeschberger ML; Coderre JA
    Radiat Res; 1994 Jan; 137(1):44-51. PubMed ID: 8265787
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vitro and in vivo evaluation of carboranyl uridines as boron delivery agents for neutron capture therapy.
    Liu L; Barth RF; Tjarks W; Soloway AH; Anisuzzaman AK
    Anticancer Res; 1996; 16(1):113-20. PubMed ID: 8615595
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Porphyrin-mediated boron neutron capture therapy: evaluation of the reactions of skin and central nervous system.
    Morris GM; Coderre JA; Hopewell JW; Micca PL; Nawrocky M; Miura M
    Int J Radiat Biol; 2003 Mar; 79(3):149-58. PubMed ID: 12745879
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vivo evaluation of phosphorous-containing derivatives of dodecahydro-closo-dodecaborate for boron neutron capture therapy of gliomas and sarcomas.
    Tjarks W; Barth RF; Rotaru JH; Adams DM; Yang W; Kultyshev RG; Forrester J; Barnum BA; Soloway AH; Shore SG
    Anticancer Res; 2001; 21(2A):841-6. PubMed ID: 11396173
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Boron lipid-based liposomal boron delivery system for neutron capture therapy: recent development and future perspective.
    Nakamura H
    Future Med Chem; 2013 Apr; 5(6):715-30. PubMed ID: 23617433
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synthesis and biological evaluation of boronated nucleosides for boron neutron capture therapy (BNCT) of cancer.
    Tjarks W; Wang J; Chandra S; Ji W; Zhuo J; Lunato AJ; Boyer C; Li Q; Usova EV; Eriksson S; Morrison GH; Cosquer GY
    Nucleosides Nucleotides Nucleic Acids; 2001; 20(4-7):695-8. PubMed ID: 11563094
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Boronated thymidine analogues for boron neutron capture therapy.
    Thirumamagal BT; Johnsamuel J; Cosquer GY; Byun Y; Yan J; Narayanasamy S; Tjarks W; Barth RF; Al-Madhoun AS; Eriksson S
    Nucleosides Nucleotides Nucleic Acids; 2006; 25(8):861-6. PubMed ID: 16901817
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Use of dimercaptocarborane derivatives in neutron capture therapy].
    Spryshkova RA; Bratsev VA; Shabalkin IP
    Med Radiol (Mosk); 1980 Nov; 25(11):46-50. PubMed ID: 7442488
    [No Abstract]   [Full Text] [Related]  

  • 40. A critical assessment of boron target compounds for boron neutron capture therapy.
    Hawthorne MF; Lee MW
    J Neurooncol; 2003; 62(1-2):33-45. PubMed ID: 12749701
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.